Literature DB >> 11523260

A study on the expression of interleukin (IL)-10 and IL-12 P35, P40 mRNA in the psoriatic lesions.

J Cheng1, Y Tu, J Li, C Huang, Z Liu, D Liu.   

Abstract

To investigate the possible role of interleukin (IL)-10 and IL-12 in the pathogenesis of psoriatic lesions and to supply theoretical basis for the gene therapy for psoriasis, the expression of IL-10 and IL-12 P35, P40 mRNA in 12 cases of psoriatic lesions and 6 normal skin tissues was detected by using RT-PCR technique. The results showed that the expression of IL-10 mRNA in the psoriatic lesions was significantly lower than that in the normal skin tissues (P < 0.001). The expression of IL-12 P35 was positive both in the psoriatic lesions and in the normal skin tissues. IL-12 P40 mRNA was expressed positively only in the psoriatic lesions but negatively in the normal skin tissues. It was suggested that IL-12 might take an important role in the occurrence and progression of psoriasis, but IL-10 might have certain role in the regression of psoriasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11523260     DOI: 10.1007/BF02888047

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  6 in total

1.  The cytokine network in psoriasis.

Authors:  B J Nickoloff
Journal:  Arch Dermatol       Date:  1991-06

2.  IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.

Authors:  K Asadullah; W Sterry; K Stephanek; D Jasulaitis; M Leupold; H Audring; H D Volk; W D Döcke
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

3.  Expression of interleukin-12 is increased in psoriatic skin.

Authors:  N Yawalkar; S Karlen; R Hunger; C U Brand; L R Braathen
Journal:  J Invest Dermatol       Date:  1998-12       Impact factor: 8.551

4.  IL-10 inhibits cytokine production by activated macrophages.

Authors:  D F Fiorentino; A Zlotnik; T R Mosmann; M Howard; A O'Garra
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

5.  Interleukin-10 inhibits IgE-mediated nitric oxide synthase induction and cytokine synthesis in normal human keratinocytes.

Authors:  P A Bécherel; L Le Goff; S Ktorza; F Ouaaz; J M Mencia-Huerta; B Dugas; P Debré; M D Mossalayi; M Arock
Journal:  Eur J Immunol       Date:  1995-10       Impact factor: 5.532

6.  Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression.

Authors:  R S Mitra; T A Judge; F O Nestle; L A Turka; B J Nickoloff
Journal:  J Immunol       Date:  1995-03-15       Impact factor: 5.422

  6 in total
  7 in total

Review 1.  Interleukin-23: as a drug target for autoimmune inflammatory diseases.

Authors:  Chunlei Tang; Shu Chen; Hai Qian; Wenlong Huang
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

2.  IL-10 implications in psoriasis.

Authors:  Ahmad A Al-Robaee; Abdullateef A Al-Zolibani; Hani A Al-Shobili; Amira Kazamel; Ahmad Settin
Journal:  Int J Health Sci (Qassim)       Date:  2008-01

3.  Lack of association of the IL-1RN and IL-10 polymorphisms with risk of psoriasis: A meta-analysis.

Authors:  Ju Qiao; Qian-Nan Jia; Hong-Zhong Jin
Journal:  Mol Genet Genomic Med       Date:  2018-12-06       Impact factor: 2.183

4.  Th1, Th17, and Treg Responses are Differently Modulated by TNF-α Inhibitors and Methotrexate in Psoriasis Patients.

Authors:  Sandro C Furiati; Jonatas S Catarino; Marcos V Silva; Rafaela F Silva; Rayane B Estevam; Reginaldo B Teodoro; Sanivia L Pereira; Meire Ataide; Virmondes Rodrigues; Denise B R Rodrigues
Journal:  Sci Rep       Date:  2019-05-17       Impact factor: 4.379

5.  CD1a expression in psoriatic skin following treatment with propylthiouracil, an antithyroid thioureylene.

Authors:  Alan N Elias; Vandana S Nanda; Ronald J Barr
Journal:  BMC Dermatol       Date:  2003-07-03

Review 6.  Current Developments in the Immunology of Psoriasis.

Authors:  Franziska Grän; Andreas Kerstan; Edgar Serfling; Matthias Goebeler; Khalid Muhammad
Journal:  Yale J Biol Med       Date:  2020-03-27

7.  An Analysis of IL-10, IL-17A, IL-17RA, IL-23A and IL-23R Expression and Their Correlation with Clinical Course in Patients with Psoriasis.

Authors:  Magdalena Kutwin; Monika Migdalska-Sęk; Ewa Brzeziańska-Lasota; Piotr Zelga; Anna Woźniacka
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.